Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis

Inclusion Criteria: * DVT confirmed by venographic and ultrasound imaging, which has been symptomatic for a maximum of 14 days, or diagnosed within past 14 days defined as either first episode (no prior history in affected segment), or recurrent episode. * Written informed consent * Agreement to comply with follow up requirements Exclusion Criteria: * Known R-L shunt, pulmonary A-V malformation * Excessive tortuosity and/or sharp angulation in target treatment zone * Isolated calf vein thrombosis * Isolated DVT in veins peripheral to axillary vein * Thrombus in peripheral vessel smaller than 5 mm * Target treatment zone cannot be adequately accessed within the 100 cm working length of device